| NDC Code | 43528-003-05 |
|---|
| Package Description | 5 SYRINGE in 1 CARTON (43528-003-05) / .5 mL in 1 SYRINGE (43528-003-01) |
|---|
| Product NDC | 43528-003 |
|---|
| Product Type Name | VACCINE |
|---|
| Proprietary Name | Heplisav-b |
|---|
| Non-Proprietary Name | Hepatitis B Vaccine (recombinant) Adjuvanted |
|---|
| Dosage Form | INJECTION, SOLUTION |
|---|
| Usage | INTRAMUSCULAR |
|---|
| Start Marketing Date | 20180101 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA125428 |
|---|
| Manufacturer | Dynavax Technologies Corporation |
|---|
| Substance Name | HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN |
|---|
| Strength | 20 |
|---|
| Strength Unit | ug/.5mL |
|---|
| Pharmacy Classes | Actively Acquired Immunity [PE], Hepatitis B Vaccines [CS], Inactivated Hepatitis B Virus Vaccine [EPC], Vaccines, Inactivated [CS] |
|---|